NanoViricides (NNVC) Competitors $1.75 +0.05 (+2.94%) Closing price 04:00 PM EasternExtended Trading$1.77 +0.02 (+1.14%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NNVC vs. SAVA, CRBP, HLVX, TCRX, CHRS, CLYM, ZNTL, OKYO, CLLS, and CRDLShould you be buying NanoViricides stock or one of its competitors? The main competitors of NanoViricides include Cassava Sciences (SAVA), Corbus Pharmaceuticals (CRBP), HilleVax (HLVX), TScan Therapeutics (TCRX), Coherus Oncology (CHRS), Climb Bio (CLYM), Zentalis Pharmaceuticals (ZNTL), OKYO Pharma (OKYO), Cellectis (CLLS), and Cardiol Therapeutics (CRDL). These companies are all part of the "pharmaceutical products" industry. NanoViricides vs. Its Competitors Cassava Sciences Corbus Pharmaceuticals HilleVax TScan Therapeutics Coherus Oncology Climb Bio Zentalis Pharmaceuticals OKYO Pharma Cellectis Cardiol Therapeutics Cassava Sciences (NASDAQ:SAVA) and NanoViricides (NYSE:NNVC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Does the media prefer SAVA or NNVC? In the previous week, NanoViricides had 2 more articles in the media than Cassava Sciences. MarketBeat recorded 3 mentions for NanoViricides and 1 mentions for Cassava Sciences. NanoViricides' average media sentiment score of 0.45 beat Cassava Sciences' score of 0.00 indicating that NanoViricides is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cassava Sciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NanoViricides 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has better valuation & earnings, SAVA or NNVC? NanoViricides is trading at a lower price-to-earnings ratio than Cassava Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCassava SciencesN/AN/A-$24.34M-$1.50-1.80NanoViricidesN/AN/A-$8.29M-$0.70-2.50 Is SAVA or NNVC more profitable? Cassava Sciences' return on equity of -87.72% beat NanoViricides' return on equity.Company Net Margins Return on Equity Return on Assets Cassava SciencesN/A -87.72% -72.05% NanoViricides N/A -87.90%-78.69% Do institutionals & insiders believe in SAVA or NNVC? 38.1% of Cassava Sciences shares are held by institutional investors. Comparatively, 10.3% of NanoViricides shares are held by institutional investors. 2.4% of Cassava Sciences shares are held by insiders. Comparatively, 4.6% of NanoViricides shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, SAVA or NNVC? Cassava Sciences has a beta of -2.04, meaning that its share price is 304% less volatile than the S&P 500. Comparatively, NanoViricides has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Do analysts prefer SAVA or NNVC? Cassava Sciences presently has a consensus target price of $54.50, indicating a potential upside of 1,918.52%. Given Cassava Sciences' stronger consensus rating and higher probable upside, equities analysts clearly believe Cassava Sciences is more favorable than NanoViricides.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cassava Sciences 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50NanoViricides 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryCassava Sciences beats NanoViricides on 7 of the 13 factors compared between the two stocks. Get NanoViricides News Delivered to You Automatically Sign up to receive the latest news and ratings for NNVC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NNVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NNVC vs. The Competition Export to ExcelMetricNanoViricidesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$28.13M$783.79M$5.57B$20.89BDividend YieldN/A4.84%4.05%3.62%P/E Ratio-2.431.4028.0527.93Price / SalesN/A25.01428.2373.21Price / CashN/A19.5636.1922.61Price / Book2.656.928.604.70Net Income-$8.29M-$4.13M$3.24B$993.85M7 Day Performance9.37%2.20%4.63%2.94%1 Month Performance27.74%4.23%12.93%6.76%1 Year Performance-25.21%6.14%35.40%11.40% NanoViricides Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NNVCNanoViricides0.3326 of 5 stars$1.75+2.9%N/A-25.1%$28.13MN/A-2.4320High Trading VolumeSAVACassava Sciences3.7144 of 5 stars$2.30+4.1%$54.50+2,269.6%-79.9%$106.76MN/A-1.5330News CoverageCRBPCorbus Pharmaceuticals4.6575 of 5 stars$8.56+0.7%$50.88+494.3%-85.1%$104.01MN/A-2.0340HLVXHilleVax1.7392 of 5 stars$2.05-0.5%$2.00-2.4%+11.6%$103.29MN/A-0.9520TCRXTScan Therapeutics3.2386 of 5 stars$1.83+0.5%$7.80+326.2%-73.1%$103M$2.82M-1.68100CHRSCoherus Oncology3.4925 of 5 stars$0.89+0.7%$4.68+428.1%-45.7%$102.11M$266.96M-0.78330CLYMClimb Bio2.6105 of 5 stars$1.41-6.6%$9.00+538.3%N/A$102.04MN/A-0.599ZNTLZentalis Pharmaceuticals1.7039 of 5 stars$1.39-1.4%$8.37+501.9%-64.3%$101.45M$67.43M-0.44160Gap UpOKYOOKYO Pharma2.9741 of 5 stars$2.82-5.7%$7.00+148.2%+63.7%$101.17MN/A0.007CLLSCellectis2.7714 of 5 stars$1.83+0.5%$4.00+118.6%-11.5%$101.16M$49.22M-2.13290Gap UpCRDLCardiol Therapeutics2.2778 of 5 stars$1.22+2.5%$8.00+555.7%-36.9%$98.35MN/A-3.5920News CoveragePositive News Related Companies and Tools Related Companies Cassava Sciences Alternatives Corbus Pharmaceuticals Alternatives HilleVax Alternatives TScan Therapeutics Alternatives Coherus Oncology Alternatives Climb Bio Alternatives Zentalis Pharmaceuticals Alternatives OKYO Pharma Alternatives Cellectis Alternatives Cardiol Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NNVC) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoViricides, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoViricides With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NNVC Stock Alerts